Furthermore, another study revealed that treatment with resveratrol, a SIRT1 activator, weakened cardiac function and reduced cardiomyocyte apoptosis in the context of diabetic cardiomyopathy, which supports our findings in regard to SIRT1 elevation (Guo et al., 2015). This evidence concerns the gene SIRT1 and diabetic cardiomyopathy.